17,261 trials
Herpes Zoster
Primary: Geometric Mean Fold Rise (GMFR) in Varicella-Zoster (VZV) Antibody Responses Measured by Glycoprotein Enzyme-linked Immunosorbent Assay (gpELISA) — 1.57 Ratio — p=<0.0001
Constipation
Primary: Weekly Rate of Spontaneous Bowel Movements at 4 Weeks — 1.6; 1.3; 1.6; 1.3 spontaneous bowel movements per week — p=0.78
Neurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PN
Primary: Percent of Participants With a 20% or More Change in Target Tumor Volume — 0; 8; 11; 0 Participants
Ann Arbor Stage III Grade 1 Follicular Lymphoma · Ann Arbor Stage III Grade 2 Follicular Lymphoma · Ann Arbor Stage III Grade 3 Follicular Lymphoma
Primary: Complete Response Rate — .621; .597 proportion of patients
Smallpox
Primary: Related Serious Adverse Events — 0; 0 Participants
Septic Shock
Primary: Organ-failure-free Days — 26 units on a scale
Tobacco Use in Childbirth · Smoking Cessation · Pregnancy Related
Primary: Change in Cigarettes Per Day From Baseline to 4-weeks — -0.94; 0 Cigarettes smoked per day
Smallpox
Primary: Percentage of Participants With Seroconversion by ELISA — 98.9; 82.2; 3.4; 95.5 percentage of subjects
Atopic Dermatitis
Primary: Percentage of Participants With Seroconversion by ELISA — 98.5; 97.3 percentage of subjects
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
Primary: Change in Ventral Striatal Activation Occurring in Anticipation of Reward During the Monetary Incentive Delay Task Measured by fMRI — 0.718; 0.331 Z score — p=0.0095
Acute Myeloid Leukemia · Acute Lymphoid Leukemia · Hematopoetic Myelodysplasia
Primary: The Percent of Subjects Engrafting by Day +30 After Transplantation — 100 percentage of participants
Cervical Cancer
Primary: Proportion of Patients With Objective Tumor Response Rate (Complete Response [CR] or Partial Response [PR]) Using RECIST Version 1.0 — 0; 0 participants
Alcoholism
Primary: Mean Percentage of Heavy Drinking Days — 39; 42; 28 percentage of heavy drinking days — p=0.018
Oral Hygiene
Primary: Change From Baseline in Overall Macpherson Modification of the Lobene Stain Index (MLSI) at 8 Weeks. — -0.32; -0.47; -0.38; -0.40 Score on a scale — p=0.6499
Cervical Adenocarcinoma · Cervical Adenosquamous Carcinoma · Cervical Small Cell Carcinoma
Primary: Proportion of Patients With Objective Tumor Response Rate (Complete Response [CR] or Partial Response [PR]) Using RECIST Version 1.0 — 10; 0 participants